Global Information
회사소개 | 문의 | 비교리스트

무혈관성괴사 시장 : 약제 유형별, 투여 방법별, 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년)

Avascular Necrosis Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

리서치사 Coherent Market Insights
발행일 2021년 12월 상품코드 1045541
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 5,733,000 PDF (Single User License)
US $ 7,000 ₩ 8,919,000 PDF (Multi User License)
US $ 10,000 ₩ 12,742,000 PDF (Enterprise User License)


무혈관성괴사 시장 : 약제 유형별, 투여 방법별, 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년) Avascular Necrosis Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 무혈관성괴사 시장은 제품 발매 수의 증가에 의해 예측 기간에 성장이 촉진될 것으로 예상되고 있습니다.

세계의 무혈관성괴사 시장에 대해 조사분석했으며, 시장 개요, 시장 역학, COVID-19의 영향, 약제 유형·투여 방법·유통경로·지역별 시장 분석, 경쟁 구도를 정리하여 전해드립니다.

목차

제1장 조사 목적·전제조건

제2장 시장 개요

  • 리포트 설명
    • 시장의 정의와 범위
  • 개요
    • 시장 내역 : 약제 유형별
    • 시장 내역 : 유통 채널별
    • 시장 내역 : 투여 방법별
    • 시장 내역 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제 및 동향 분석

  • 촉진요인
  • 억제요인
  • 시장 기회
  • 영향 분석
  • 시장 동향
  • 최근 제품 발매/승인
  • 규제 시나리오
  • 역학
  • PEST 분석
  • 인수와 제휴 시나리오

제4장 세계의 무혈관성괴사 시장 : COVID-19의 영향

  • COVID-19 역학
  • 무혈관성괴사의 수요와 공급에 대한 COVID-19의 영향
  • 정부 구상

제5장 세계의 무혈관성괴사 시장 : 약제 유형별, 2017-2028년(100만 달러)

  • 비스테로이드성 항염증약
  • 골다공증 치료제
  • 콜레스테롤 저하제
  • 혈액 응고 저지제
  • 기타

제6장 세계의 무혈관성괴사 시장 : 투여 방법별, 2017-2028년(100만 달러)

  • 경구
  • 주사

제7장 세계의 무혈관성괴사 시장 : 유통경로별, 2017-2028년(100만 달러)

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 무혈관성괴사 시장 : 지역별, 2017-2028년(100만 달러)

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동
  • 아프리카

제9장 경쟁 구도

  • 기업 개요
    • Teva Pharmaceuticals Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Solara Active Pharma Sciences Limited.
    • Bayer AG
    • Rochem International, Inc.
    • Alkem Labs.
    • Dwarkesh Pharmaceuticals Private Limited
    • Novartis AG
    • GSK
    • Pfizer, Inc.

제10장 섹션

KSA 22.01.28

Avascular necrosis is a disease that results from the short-term or permanent loss of blood supply to the bone. This cut-off of blood supply to bone leads to tiny breaks in the bone and the bones eventually collapse. Avascular necrosis is also known as osteonecrosis. This condition may happen in any bone of the body, but mostly happens in the ends of a long bone. A broken bone or dislocated joint can interrupt the blood flow to a section of bone. Avascular necrosis condition is most common in people between the ages of 30 and 50.

Avascular necrosis can be caused due to-

  • Injury to bone
  • Fracture
  • Damage of blood vessels
  • Long-term use of medicines, such as corticosteroids
  • Excessive, long-term use of alcohol

Avascular necrosis can be diagnosed by Bone scan, Magnetic Resonance Image and Computed Tomography, and X-rays. Medications used to treat avascular necrosis are blood thinners, nonsteroidal anti-inflammatory drugs, cholesterol lowering drugs and others.

Market Dynamics

Increasing number of product launches is expected to drive the growth of global avascular necrosis market during the forecast period. For instance, in September 2014, Bayer Healthcare LLC, a pharmaceutical and medicine manufacturing company, announced the launch of Aleve PM, an over-the-counter (OTC) pain reliever product in the U.S.

Increasing number of drug approvals from regulatory bodies is expected to drive the growth of the global avascular necrosis market. For instance, in April 2019, the U.S Food and Drugs Administration approved Evenity (romosozumab-aqqg), a sclerostin inhibitor indicated to treat osteoporosis in postmenopausal women at high risk of breaking a bone.

Key features of the study:

  • This report provides an in-depth analysis of the global avascular necrosis market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global avascular necrosis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Solara Active Pharma Sciences Limited., Bayer AG, Rochem International, Inc., Alkem Labs., Dwarkesh Pharmaceuticals Private Limited., Novartis AG, GSK, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global avascular necrosis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global avascular necrosis market

Detailed Segmentation:

  • Global Avascular Necrosis Market, By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
    • Ibuprofen
    • Naproxen Sodium
    • Osteoporosis drugs
    • Cholesterol- lowering drugs
    • Blood Thinners
    • Others
  • Global Avascular Necrosis Market, By Route of Administration:
    • Oral
    • Injectable
  • Global Avascular Necrosis Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Avascular Necrosis Market, By Region:
    • North America
  • By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
      • Ibuprofen
      • Naproxen Sodium
    • Osteoporosis drugs
    • Cholesterol-lowering drugs
    • Blood Thinners
    • Others
  • By Route of Administration:
    • Oral
    • Injectable
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • U.S.
    • Canada
    • Latin America
  • By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
      • Ibuprofen
      • Naproxen Sodium
    • Osteoporosis drugs
    • Cholesterol-lowering drugs
    • Blood Thinners
    • Others
  • By Route of Administration:
    • Oral
    • Injectable
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
      • Ibuprofen
      • Naproxen Sodium
    • Osteoporosis drugs
    • Cholesterol-lowering drugs
    • Blood Thinners
    • Others
  • By Route of Administration:
    • Oral
    • Injectable
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
      • Ibuprofen
      • Naproxen Sodium
    • Osteoporosis drugs
    • Cholesterol-lowering drugs
    • Blood Thinners
    • Others
  • By Route of Administration:
    • Oral
    • Injectable
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
      • Ibuprofen
      • Naproxen Sodium
    • Osteoporosis drugs
    • Cholesterol-lowering drugs
    • Blood Thinners
    • Others
  • By Route of Administration:
    • Oral
    • Injectable
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
      • Ibuprofen
      • Naproxen Sodium
    • Osteoporosis drugs
    • Cholesterol-lowering drugs
    • Blood Thinners
    • Others
  • By Route of Administration:
    • Oral
    • Injectable
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Teva Pharmaceuticals Industries Ltd. *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Dr. Reddy's Laboratories Ltd.
  • Solara Active Pharma Sciences Limited.
  • Bayer AG
  • Rochem International, Inc.
  • Alkem Labs
  • Dwarkesh Pharmaceuticals Private Limited
  • Novartis AG
  • GSK
  • Pfizer, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Route of Administration
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Product Launches/Approvals
  • Regulatory Scenario
  • Epidemiology
  • PEST Analysis
  • Acquisition and Collaboration Scenario

4. Impact of COVID-19 on the Global Avascular Necrosis Market

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Avascular Necrosis.
  • Government Initiative

5. Global Avascular Necrosis Market, By Drug Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Nonsteroidal anti-inflammatory drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Ibuprofen
    • Naproxen Sodium
  • Osteoporosis drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Cholesterol-lowering drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Blood Thinners
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Avascular Necrosis Market, By Route of Administration, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Ibuprofen
    • Naproxen Sodium
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Avascular Necrosis Market, By Distribution Channel, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Avascular Necrosis Market, By Region, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Company Profiles
    • Teva Pharmaceuticals Industries Ltd.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Dr. Reddy's Laboratories Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Solara Active Pharma Sciences Limited.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Rochem International, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Alkem Labs.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Dwarkesh Pharmaceuticals Private Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GSK
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q